| Year |
Citation |
Score |
| 2023 |
Yano H, Chitsazi R, Lucaj C, Tran P, Hoffman AF, Baumann MH, Lupica CR, Shi L. Subtle Structural Modification of a Synthetic Cannabinoid Receptor Agonist Drastically Increases its Efficacy at the CB1 Receptor. Acs Chemical Neuroscience. 14: 3928-3940. PMID 37847546 DOI: 10.1021/acschemneuro.3c00530 |
0.673 |
|
| 2023 |
Yano H, Chitsazi R, Lucaj C, Tran P, Hoffman AF, Baumann MH, Lupica CR, Shi L. A subtle structural modification of a synthetic cannabinoid receptor agonist drastically increases its efficacy at the CB1 receptor. Biorxiv : the Preprint Server For Biology. PMID 37398099 DOI: 10.1101/2023.06.10.544442 |
0.683 |
|
| 2023 |
Park JC, Luebbers A, Dao M, Semeano A, Nguyen AM, Papakonstantinou MP, Broselid S, Yano H, Martemyanov KA, Garcia-Marcos M. Fine-tuning GPCR-mediated neuromodulation by biasing signaling through different G protein subunits. Molecular Cell. PMID 37390816 DOI: 10.1016/j.molcel.2023.06.006 |
0.336 |
|
| 2022 |
Pavletić P, Semeano A, Yano H, Bonifazi A, Giorgioni G, Piergentili A, Quaglia W, Sabbieti MG, Agas D, Santoni G, Pallini R, Ricci-Vitiani L, Sabato E, Vistoli G, Del Bello F. Highly Potent and Selective Dopamine D Receptor Antagonists Potentially Useful for the Treatment of Glioblastoma. Journal of Medicinal Chemistry. 65: 12124-12139. PMID 36098685 DOI: 10.1021/acs.jmedchem.2c00840 |
0.405 |
|
| 2021 |
Adhikari P, Xie B, Semeano A, Bonifazi A, Battiti FO, Newman AH, Yano H, Shi L. Chirality of Novel Bitopic Agonists Determines Unique Pharmacology at the Dopamine D3 Receptor. Biomolecules. 11. PMID 33924613 DOI: 10.3390/biom11040570 |
0.513 |
|
| 2020 |
Yano H, Adhikari P, Naing S, Hoffman AF, Baumann MH, Lupica CR, Shi L. Positive allosteric modulation of the 5-HT receptor by indole-based synthetic cannabinoids abused by humans. Acs Chemical Neuroscience. PMID 32324370 DOI: 10.1021/Acschemneuro.0C00034 |
0.643 |
|
| 2020 |
Sanchez-Soto M, Verma RK, Willette BKA, Gonye EC, Moore AM, Moritz AE, Boateng CA, Yano H, Free RB, Shi L, Sibley DR. A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity. Science Signaling. 13. PMID 32019899 DOI: 10.1126/Scisignal.Aaw5885 |
0.455 |
|
| 2020 |
Lane JR, Abramyan AM, Adhikari P, Keen AC, Lee KH, Sanchez J, Verma RK, Lim HD, Yano H, Javitch JA, Shi L. Distinct inactive conformations of the dopamine D2 and D3 receptors correspond to different extents of inverse agonism. Elife. 9. PMID 31985399 DOI: 10.7554/Elife.52189 |
0.395 |
|
| 2020 |
Köfalvi A, Moreno E, Cordomí A, Cai NS, Fernández-Dueñas V, Ferreira SG, Guixà-González R, Sánchez-Soto M, Yano H, Casadó-Anguera V, Cunha RA, Sebastião AM, Ciruela F, Pardo L, Casadó V, et al. Control of glutamate release by complexes of adenosine and cannabinoid receptors. Bmc Biology. 18: 9. PMID 31973708 DOI: 10.1186/S12915-020-0739-0 |
0.423 |
|
| 2019 |
Yano H, Liu L, Naing S, Shi L. The Effects of Terminal Tagging on Homomeric Interactions of the Sigma 1 Receptor. Frontiers in Neuroscience. 13: 1356. PMID 31920515 DOI: 10.3389/Fnins.2019.01356 |
0.324 |
|
| 2019 |
Francis TC, Yano H, Demarest TG, Shen H, Bonci A. High-Frequency Activation of Nucleus Accumbens D1-MSNs Drives Excitatory Potentiation on D2-MSNs. Neuron. PMID 31221559 DOI: 10.1016/J.Neuron.2019.05.031 |
0.336 |
|
| 2019 |
Bonifazi A, Yano H, Guerrero AM, Kumar V, Hoffman AF, Lupica CR, Shi L, Newman AH. Novel and Potent Dopamine D Receptor Go-Protein Biased Agonists. Acs Pharmacology & Translational Science. 2: 52-65. PMID 30775693 DOI: 10.1021/acsptsci.8b00060 |
0.654 |
|
| 2018 |
Yano H, Cai NS, Javitch JA, Ferré S. Luciferase complementation based-detection of G-protein-coupled receptor activity. Biotechniques. 65: 9-14. PMID 30014734 DOI: 10.2144/Btn-2018-0039 |
0.393 |
|
| 2018 |
Del Bello F, Bonifazi A, Giorgioni G, Cifani C, Micioni Di Bonaventura MV, Petrelli R, Piergentili A, Fontana S, Mammoli V, Yano H, Matucci R, Vistoli G, Quaglia W. 1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1) as a Model for the Rational Design of a Novel Class of Brain Penetrant Ligands with High Affinity and Selectivity for Dopamine D4 Receptor. Journal of Medicinal Chemistry. PMID 29589445 DOI: 10.1021/Acs.Jmedchem.8B00265 |
0.36 |
|
| 2018 |
Sánchez-Soto M, Casadó-Anguera V, Yano H, Bender BJ, Cai NS, Moreno E, Canela EI, Cortés A, Meiler J, Casadó V, Ferré S. α- and α-Adrenoceptors as Potential Targets for Dopamine and Dopamine Receptor Ligands. Molecular Neurobiology. PMID 29552726 DOI: 10.1007/S12035-018-1004-1 |
0.368 |
|
| 2018 |
Yano H, Bonifazi A, Xu M, Guthrie DA, Schneck SN, Abramyan AM, Fant AD, Hong WC, Newman AH, Shi L. Pharmacological profiling of sigma 1 receptor ligands by novel receptor homomer assays. Neuropharmacology. PMID 29407216 DOI: 10.1016/J.Neuropharm.2018.01.042 |
0.417 |
|
| 2018 |
Yano H, Cai NS, Xu M, Verma RK, Rea W, Hoffman AF, Shi L, Javitch JA, Bonci A, Ferré S. Gs- versus Golf-dependent functional selectivity mediated by the dopamine D1 receptor. Nature Communications. 9: 486. PMID 29402888 DOI: 10.1038/S41467-017-02606-W |
0.646 |
|
| 2017 |
Yano H, Sánchez-Soto M, Ferré S. Bioluminescence Resonance Energy Transfer Assay to Characterize Gi-Like G Protein Subtype-Dependent Functional Selectivity. Current Protocols in Neuroscience. 81: 5.33.1-5.33.13. PMID 29058771 DOI: 10.1002/Cpns.38 |
0.39 |
|
| 2017 |
Yano H, Provasi D, Cai NS, Filizola M, Ferre S, Javitch JA. Development of novel biosensors to study receptor-mediated activation of Gs and Golf. The Journal of Biological Chemistry. PMID 29042444 DOI: 10.1074/Jbc.M117.800698 |
0.586 |
|
| 2017 |
Hong WC, Yano H, Hiranita T, Chin FT, McCurdy CR, Su TP, Amara SG, Katz JL. The sigma-1 receptor modulates dopamine transporter conformation and cocaine binding and may thereby potentiate cocaine self-administration in rats. The Journal of Biological Chemistry. PMID 28495886 DOI: 10.1074/Jbc.M116.774075 |
0.305 |
|
| 2017 |
Bonifazi A, Yano H, Ellenberger MP, Muller L, Kumar V, Zou MF, Cai NS, Guerrero AM, Woods AS, Shi L, Newman AH. Novel Bivalent Ligands Based on the Sumanirole Pharmacophore Reveal Dopamine D2 Receptor (D2R) Biased Agonism. Journal of Medicinal Chemistry. PMID 28300398 DOI: 10.1021/Acs.Jmedchem.6B01875 |
0.5 |
|
| 2016 |
Michino M, Boateng CA, Donthamsetti P, Yano H, Bakare OM, Bonifazi A, Ellenberger MP, Keck TM, Kumar V, Zhu C, Verma R, Deschamps JR, Javitch JA, Newman AH, Shi L. Towards understanding the structural basis of partial agonism at the dopamine D3 receptor. Journal of Medicinal Chemistry. PMID 27983845 DOI: 10.1021/Acs.Jmedchem.6B01148 |
0.54 |
|
| 2016 |
Sanchez-Soto M, Bonifazi A, Cai NS, Ellenberger MP, Newman AH, Ferre S, Yano H. Evidence for Non-Canonical Neurotransmitter Activation: Norepinephrine as a Dopamine D2-like Receptor Agonist. Molecular Pharmacology. PMID 26843180 DOI: 10.1124/Mol.115.101808 |
0.527 |
|
| 2014 |
Guitart X, Navarro G, Moreno E, Yano H, Cai NS, Sánchez-Soto M, Kumar-Barodia S, Naidu YT, Mallol J, Cortés A, Lluís C, Canela EI, Casadó V, McCormick PJ, Ferré S. Functional selectivity of allosteric interactions within G protein-coupled receptor oligomers: the dopamine D1-D3 receptor heterotetramer. Molecular Pharmacology. 86: 417-29. PMID 25097189 DOI: 10.1124/Mol.114.093096 |
0.546 |
|
| 2011 |
Urizar E, Yano H, Kolster R, Galés C, Lambert N, Javitch JA. CODA-RET reveals functional selectivity as a result of GPCR heteromerization. Nature Chemical Biology. 7: 624-30. PMID 21785426 DOI: 10.1038/Nchembio.623 |
0.552 |
|
| 2009 |
Sohy D, Yano H, de Nadai P, Urizar E, Guillabert A, Javitch JA, Parmentier M, Springael JY. Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the protean effects of "selective" antagonists. The Journal of Biological Chemistry. 284: 31270-9. PMID 19758998 DOI: 10.1074/Jbc.M109.054809 |
0.501 |
|
| Show low-probability matches. |